KIT and systemic mastocytosis: Thus, HMC-1.3 cells modified by CRISPR/Cas9 from the parental HMC-1.2 cell line may represent, in conjunction with the ROSAKIT D816V cell line created by lentiviral transduction of D816V-KIT (53), more representative mast cell models for systemic mastocytosis.